Security key
04351P101
Ascendis Pharma A/S - American Depositary Shares (ASND)
CUSIP: 04351P101
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / American Depositary Shares
- Shares outstanding
- 61,990,867
- Total 13F shares
- 62,895,390
- Share change
- -2,307,564
- Total reported value
- $10,855,906,781
- Put/Call ratio
- 33%
- Price per share
- $172.60
- Number of holders
- 245
- Value change
- -$373,773,069
- Number of buys
- 124
- Number of sells
- 127
Report period
Q2 2025
Institutions
245
Top holders
10
ASND full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Ascendis Pharma A/S SEC filings
Ascendis Pharma A/S company facts
Broader feeds
Reporting periods
Holder history for CUSIP 04351P101
Recent filing periods:
Top shareholders of ASND - Ascendis Pharma A/S - American Depositary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital International Investors |
13D/G
13F
|
Company |
5.6%
|
3,109,225
|
$548,747,120 | $0 | 30 Jun 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
17%
|
10,281,496
|
$1,602,473,967 | — | 31 Mar 2025 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
8.8%
|
5,479,259
|
$853,997,354 | — | 31 Mar 2025 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
8.4%
|
5,218,000
|
$813,277,480 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
7.5%
|
4,672,943
|
$728,324,897 | — | 31 Mar 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
7.2%
|
4,486,949
|
$693,952,439 | — | 31 Mar 2025 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
6.9%
|
4,256,627
|
$663,437,884 | — | 31 Mar 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
4.9%
|
3,053,824
|
$475,970,000 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3.6%
|
2,256,102
|
$351,637,000 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
3.1%
|
1,903,531
|
$296,684,341 | — | 31 Mar 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
3%
|
1,877,917
|
$292,692,144 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2.6%
|
1,640,121
|
$255,629,196 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
1.9%
|
1,198,478
|
$186,794,782 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.8%
|
1,125,183
|
$175,371,023 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.1%
|
679,943
|
$105,975,916 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.95%
|
587,763
|
$91,608,742 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.94%
|
585,581
|
$91,268,654 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.92%
|
569,146
|
$88,707,165 | — | 31 Mar 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.85%
|
525,000
|
$81,826,500 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.83%
|
517,154
|
$80,603,624 | — | 31 Mar 2025 | |
| FIL Ltd |
13F
|
Company |
0.75%
|
462,366
|
$72,064,365 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.75%
|
462,171
|
$72,034,082 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.7%
|
432,098
|
$67,346,794 | — | 31 Mar 2025 | |
| Camber Capital Management LP |
13F
|
Company |
0.56%
|
350,000
|
$54,551,000 | — | 31 Mar 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.56%
|
346,018
|
$53,930,365 | — | 31 Mar 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.55%
|
343,390
|
$53,520,765 | — | 31 Mar 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.53%
|
330,153
|
$51,457,000 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.53%
|
327,405
|
$51,029,343 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.49%
|
304,806
|
$47,507,063 | — | 31 Mar 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
0.46%
|
287,366
|
$44,788,865 | — | 31 Mar 2025 | |
| ARS Investment Partners, LLC |
13F
|
Company |
0.43%
|
265,164
|
$36,505,128 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.43%
|
264,867
|
$41,282,171 | — | 31 Mar 2025 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.42%
|
258,013
|
$40,213,896 | — | 31 Mar 2025 | |
| Q Global Advisors, LLC |
13F
|
Company |
0.4%
|
248,887
|
$38,792,000 | — | 31 Mar 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.39%
|
242,761
|
$37,836,729 | — | 31 Mar 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.35%
|
216,000
|
$33,665,760 | — | 31 Mar 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.33%
|
204,482
|
$31,870,565 | — | 31 Mar 2025 | |
| Saturn V Capital Management LP |
13F
|
Company |
0.32%
|
199,264
|
$31,057,287 | — | 31 Mar 2025 | |
| Catalio Capital Management, LP |
13F
|
Company |
0.32%
|
195,523
|
$30,474,215 | — | 31 Mar 2025 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.31%
|
189,613
|
$28,713,097 | — | 31 Mar 2025 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.3%
|
186,916
|
$29,132,728 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.3%
|
185,122
|
$28,853,114 | — | 31 Mar 2025 | |
| Finepoint Capital LP |
13F
|
Company |
0.29%
|
179,872
|
$28,034,850 | — | 31 Mar 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.28%
|
174,913
|
$27,262,000 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.28%
|
173,841
|
$27,094,858 | — | 31 Mar 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.28%
|
171,731
|
$26,765,994 | — | 31 Mar 2025 | |
| Resolute Capital Asset Partners LLC |
13F
|
Company |
0.27%
|
167,500
|
$26,106,550 | — | 31 Mar 2025 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.26%
|
160,796
|
$25,061,665 | — | 31 Mar 2025 | |
| Duquesne Family Office LLC |
13F
|
Company |
0.26%
|
158,720
|
$24,738,000 | — | 31 Mar 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.24%
|
151,829
|
$23,664,068 | — | 31 Mar 2025 |
Institutional Holders of Ascendis Pharma A/S - American Depositary Shares (ASND) as of Q2 2025
As of 30 Jun 2025,
Ascendis Pharma A/S - American Depositary Shares (ASND) was held by
245 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
62,895,390 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., WESTFIELD CAPITAL MANAGEMENT CO LP, Avoro Capital Advisors LLC, FMR LLC, JANUS HENDERSON GROUP PLC, Artisan Partners Limited Partnership, T. Rowe Price Investment Management, Inc., Capital International Investors, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
247
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
241
Q2 2025 holders
245
Holder diff
4
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.